Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 7—July 2025
Dispatch
Lyme Disease Testing Practices, Wisconsin, USA, 2016–2019
Table 2
Lyme disease serologic resting episodes and repeat positive results per year for Lyme disease testing practices, Wisconsin, USA, 2016–2019*
Year | No. serologic testing episodes (% positive) | No. positive in a prior year/no. positive (%) | No. (%) persons |
||
---|---|---|---|---|---|
Prior positive in 2016 | Prior positive in 2017 | Prior positive in 2018 | |||
2016 | 11,878 (6.7) | NA | NA | NA | NA |
2017 | 12,150 (7.9) | 54/928 (5.8) | 54 (5.8) | NA | NA |
2018 | 9,444 (6.2) | 86/563 (15.3) | 33 (5.9) | 56 (10.0) | NA |
2019 | 8,605 (6.6) | 81/545 (14.9) | 26 (4.8) | 33 (6.1) | 37 (6.8) |
*Some tested positive in >1 prior year. Thus, year-specific columns sum to more than the total number of persons in that year who had previously tested positive.
Page created: May 09, 2025
Page updated: May 22, 2025
Page reviewed: May 22, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.